Found: 7
Select item for more details and to access through your institution.
Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity.
- Published in:
- Molecular Biology Reports, 2013, v. 40, n. 9, p. 5315, doi. 10.1007/s11033-013-2632-1
- By:
- Publication type:
- Article
An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior.
- Published in:
- Journal of Biomedical Materials Research, Part B: Applied Biomaterials, 2015, v. 103, n. 3, p. 618, doi. 10.1002/jbm.b.33214
- By:
- Publication type:
- Article
Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Corrigendum to “Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats”.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2015, v. 2015, p. 1, doi. 10.1155/2015/278951
- By:
- Publication type:
- Article
Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11400-5
- By:
- Publication type:
- Article
DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
- Published in:
- Journal of Gene Medicine, 2006, v. 8, n. 9, p. 1182, doi. 10.1002/jgm.941
- By:
- Publication type:
- Article
High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 1, p. 37, doi. 10.1007/s11060-018-2928-z
- By:
- Publication type:
- Article